Skip to main content
Tatyana Feldman, MD, Hematology, Hackensack, NJ, Hackensack Meridian Health Hackensack University Medical Center

TatyanaAFeldmanMD

Hematology • Hackensack, NJ

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Physician

Request Appointment

Overview of Dr. Feldman

As an attending physician in the Lymphoma Division and director of the T-Cell Lymphoma Program at John Theurer Cancer Center, I am optimistic that current research into intercellular mechanisms can generate effective new therapies for treating this rare type of lymphoma. Immunotherapy, specifically CAR-T 19 cells that are genetically modified to attack lymphoma cells, is an especially exciting new approach.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2001
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1999 - 2000
  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1995 - 1999
  • Minsk Medical Institute
    Minsk Medical InstituteClass of 1992

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1998 - 2026
  • NJ State Medical License
    NJ State Medical License 2002 - 2025
  • DC State Medical License
    DC State Medical License 2019 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2016
  • Top Doctors: New York Metro Area Castle Connolly, 2014
  • Inside Jersey Top Doctors for Cancer Castle Connolly, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 Study
    Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and C...
    Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Preliminary Results from a Phase 2 Trial of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in...
    Tatyana A. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Cost-Effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Older Patients (pts) with Previously Untreated Classical Hodgkin Lymphoma (cHL): A Detailed Analysis from the Phase 3 ECHELON-1 Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Classic Hodgkin Lymphoma: Part 3 (Concurrent Dosing) Resul... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • 2022 N.J. Top Cancer Doctors Deliver Quality and Compassionate Care, Close to Home
    2022 N.J. Top Cancer Doctors Deliver Quality and Compassionate Care, Close to HomeJune 16th, 2022
  • N.J.’s 2021 Top Cancer Doctors Lead Charge to Help Patients Thrive and Survive After Pandemic
    N.J.’s 2021 Top Cancer Doctors Lead Charge to Help Patients Thrive and Survive After PandemicJune 17th, 2021
  • John Theurer Cancer Center's Dr. Andre Goy Co-Chairs 21st Annual International Congress on Hematologic Malignancies
    John Theurer Cancer Center's Dr. Andre Goy Co-Chairs 21st Annual International Congress on Hematologic MalignanciesFebruary 27th, 2017

Professional Memberships

Other Languages

  • Russian

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AmeriHealth Direct POS
    Amerihealth HMO
    AmeriHealth PPO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Healthfirst New York
    Horizon BCBS Direct Access
    Horizon BCBS HMO
    Horizon BCBS POS
    Horizon BCBS PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Tatyana Feldman, Dr. Tatyana Feldman, MD, Dr. T Feldman, Dr. Tatyana A Feldman